English 
Italian 
Spanish 
Thai 
Japanese 
Portuguese 
Korean 
Russian 
French 
German 
Polish 
Arabic 
Indonesian STRIVE FOR EXCELLENCE SERVE FOR HEALTH
WE SPECIALIZE IN PRODUCTION OF HIGH-QUALITY GENERIC DRUGS AND NEW DRUG INTERMEDIATES.
![(3S)-(7-BroMo-2-oxo-5-pyridin-2-yl-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)-propionic acid Methyl ester](/uploads/upload/20260805/260P5102951X3.webp "(3S)-(7-BroMo-2-oxo-5-pyridin-2-yl-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)-propionic acid Methyl ester")
![2-Chloro-N-[2-(2-chlorobenzoyl)-4-nitrophenyl]- benzamide](/uploads/upload/20260812/260Q2110255W6.webp "2-Chloro-N-[2-(2-chlorobenzoyl)-4-nitrophenyl]- benzamide")
![5-(1-Methyl-4-Piperidyl)-5H-Dibenzo[a,d]-Cyclophen-5-ol](/uploads/upload/20260812/260Q211000A35.png "5-(1-Methyl-4-Piperidyl)-5H-Dibenzo[a,d]-Cyclophen-5-ol")
Jiangsu Jingye Pharmaceutical, formerly known as Jingye Medical Technology Research Institute, was established in 1994 and transformed into a pharmaceutical enterprise in 2016. After more than 20 years of development, Jingye Pharmaceutical has grown into a professional and comprehensive pharmaceutical enterprise that integrates research and development, production, import and export.
Years of Development
Total Area
Meets GMP, ISO9001, ISO14001 & GB/T 45001
Products sold to Europe, America, Asia
Our products focus on three core areas: pharmaceutical raw materials, intermediates, and custom synthesis, covering CNS, cardiovascular, and dermatological treatments. They support both lab R&D and industrial production. Detailed product applications and industry coverage are outlined below:
